¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximum Strength SnapBack Stimulant Powders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • cardiac stimulant
    ½ÉÀåÀÚ±ØÁ¦, °­½ÉÁ¦
  • general stimulant
    Àü½ÅÀÚ±ØÁ¦
  • psychomotor stimulant
    Á¤½Å¿îµ¿ÀÚ±ØÁ¦
  • receptor stimulant
    ¼ö¿ëüÀÚ±ØÁ¦
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦
  • stimulant
    1. Àڱؼº- 2. ÀÚ±ØÁ¦, ÈïºÐÁ¦
  • stimulant expectorant
    Àڱؼº°¡·¡¾à, ºÐºñÀڱذ¡·¡¾à
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕ°­µµ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stimulant
    ÀÚ±ØÁ¦, ÈïºÐÁ¦
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦
  • maximum dose
    ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
  • maximum
    ÃÖ´ë
  • scatter-maximum ratio
    ÃÖ´ë»ê¶õºñ
  • strength
    Èû, ¼¼±â
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • physical strength
    ü·Â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • cardiac stimulant
    ½ÉÀåÀÚ±ØÁ¦, °­½ÉÁ¦
  • stimulant diuretic
    ÀÚ±ØÀÌ´¢Á¦
  • stimulant expectorant
    Àڱؼº°¡·¡¾à, ºÐºñÀڱذ¡·¡¾à
  • ganglion stimulant
    ½Å°æÀýÀÚ±ØÁ¦
  • general stimulant
    Àü½ÅÀÚ±ØÁ¦
  • muscle stimulant
    ±ÙÀ°ÀÚ±ØÁ¦
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
  • neuromuscular stimulant
    ½Å°æ±ÙÀ°ÀÚ±ØÁ¦
  • ovulatory stimulant
    ¹è¶õÀÚ±ØÁ¦
  • psychomotor stimulant
    Á¤½Å¿îµ¿ÀÚ±ØÁ¦
  • receptor stimulant
    ¼ö¿ëüÀÚ±ØÁ¦
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦
  • stimulant
    ÀÚ±ØÁ¦, ÈïºÐÁ¦
  • back strength
    µîÈû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ganglion stimulant
    ½Å°æÀýÈïºÐ¾à.
  • ganglionic stimulant =g. stimulating agent
    ½Å°æÀýÈïºÐ¾à(¡­ýéÝÇå·).
  • general stimulant
    Àü½Å¼º ÈïºÐÁ¦.
  • fracture strength
    ÆÄÀý °­µµ.
  • fracture strength
    ÆÄÀý°­µµ.
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • MAC=> maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ.
  • MBC=£¾maximum breathing capacity
    ÃÖ´ëÈ£Èí(¿ë)·®, ÃÖ´ëȯ±â·®.
  • MTD=> maximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=£¾maximum tolerance dose
    ÃÖ´ë³»¿ë·®.
  • MVV=>maximum voluntary ventilation
    ÃÖ´ë ¼öÀÇȯ±â·®
  • Tm => transport maximum
    ÃÖ´ëÀ̵¿Ä¡
  • apex beat =point of maximum impulse
    ½É÷¹Úµ¿(ãýôÓÚÑÔÑ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • thermoluminescent powders
    ¿­¹ß±¤°¡·ç
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • cardiac stimulant
    °­½ÉÁ¦(Ë­ãýð¥)
  • cardiac stimulant
    ½ÉÈïºÐÁ¦.
  • ganglion stimulant
    ½Å°æÀýÈïºÐ¾à.
  • ganglionic stimulant =g. stimulating agent
    ½Å°æÀýÈïºÐ¾à(¡­ýéÝÇå·).
  • general stimulant
    Àü½Å¼º ÈïºÐÁ¦.
  • irritantia =stimulant
    Àڱؾà.
  • muscle stimulant
    ±ÙÈïºÐ¾à(ÐÉýéÝÇå·), ±ÙÈïºÐÁ¦.
  • muscle stimulant
    ±Ù ÈïºÐ¾à(ÐÉýéÝÇå·), ±Ù ÈïºÐÁ¦.
  • neuromuscular stimulant
    ½Å°æ±ÙÀÚ±ØÁ¦.
  • ovulatory stimulant
    ¹è¶õÀÚ±ØÁ¦(¾à¹°), ¹è¶õÀÚ±ØÈ£¸£¸ó.
  • ovulatory stimulant
    ¹è¶õÃËÁø¾à¹°.
  • psychomotor stimulant
    Á¤½Å¿îµ¿ÈïºÐÁ¦.
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stimulant amine
    ¾Æ¹ÎÀÚ±ØÁ¦ (í©Ð½ð¥)
  • snapback
    ±Þȸº¹(ÐáüÞÜÖ)
  • snapback DNA
    ±Þȸº¹(ÐáüÞÜÖ) DNA
  • bond strength
    °áÇÕ·Â(Ì¿ùêÕô)
  • dipole strength
    ½Ö±ØÀÚ(äªÐ¿í­) ¼¼±â
  • eluent strength
    ¿ë¸®(éÁ×î) ¼¼±â
  • ionic strength
    À̿ °­µµ(Ë­Óø)
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • maximum permissible body burden
    ÃÖ´ëü³»Çã¿ëºÎ´ã(õÌÓÞô÷Ò®úÉé»Ý¶Ó½)
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ(õÌÓÞúÉé»ÒØÓø)
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(õÌÓÞúÉé»Õá)
  • maximum stationary phase
    ÃÖ´ëÁ¤Áö±â(õÌÓÞïÎò­Ñ¢)
  • maximum velocity
    ÃÖ´ë¼Óµµ(õÌÓÞáÜÓø)
  • promoter strength
    ÇÁ·Î¸ðÅÍ °­µµ(Ë­Óø)
  • rotational strength
    ȸÀü(üÞï®) ¼¼±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë°æ»ç°­µµ
  • ovulatory stimulant
    ¹è¶õÃËÁø¾à¹°
  • stimulant
    ÀÚ±ØÁ¦, ÈïºÐÁ¦
  • maximum
    ÃÖ´ë, ÃÖ°í
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum permissible dose [=MPD]
    ÃÖ´ëÇã¿ë(¼±)·®
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
IHSS(= HCMP) Idiopathic Hypertrophic Subaortic Stenosis
  = Obstructive Idiopathic Hypertrophic Car...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
US/LS upper strength/lower strength [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DTS Diametral tensile strength
ES Ego Strength
HGS Handgrip strength
IS Ionic Strength
LISS Low ionic strength solutions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • ovulatory stimulant
    ¹è¶õ ÃËÁø ¾à¹°
  • stimulant
    ÀÚ±ØÁ¦, ÈïºÐÁ¦
  • stimulant diuretic
    Àڱؼº ÀÌ´¢ ¾à
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
  • marginal strength
    º¯¿¬ °­µµ, ¿¬´Ü °­µµ
  • physical strength
    ü·Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered.
(12 Dec 1998)
general stimulant A stimulant that affects the entire body.
(05 Mar 2000)
stimulant 1. Producing stimulation, especially producing stimulation by causing tension on muscle fibre through the nervous tissue.
2. <pharmacology> An agent or remedy that produces stimulation.
Origin: L. Stimulans
(18 Nov 1997)
diffusible stimulant A stimulant that produces a rapid but temporary effect.
(05 Mar 2000)
local stimulant A stimulant whose action is confined to the part to which it is applied.
(05 Mar 2000)
maximum 1. The greatest possible or actual effect or quantity.
2. The acme of a disease or process.
(18 Nov 1997)
maximum breathing capacity The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.).
Synonym: maximum breathing capacity.
(05 Mar 2000)
maximum occipital point The point on the squama of the occipital bone farthest from the glabella.
(05 Mar 2000)
maximum permissible dose <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime.
This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large.
(05 Mar 2000)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
maximum temperature In bacteriology, denoting a temperature above which growth will not take place.
(05 Mar 2000)
maximum urea clearance The urea clearance when the urine flow exceeds 2 ml/min; normal value is about 75 ml blood/min per 1.73 m2 body surface area.
(05 Mar 2000)
maximum velocity The maximum rate of an enzyme-catalyzed reaction that can be achieved by progressively increasing the substrate concentration at a given enzyme concentration; in cases of substrate inhibition, Vmax is an extrapolated value in the absence of such inhibition; Cf.: Michaelis-Menten equation.
The maximum initial rate of shortening of a myocardial fibre that can be obtained under zero load; used to evaluate the contractility of the fibre.
(05 Mar 2000)
maximum voluntary ventilation The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.).
Synonym: maximum breathing capacity.
(05 Mar 2000)
tubular maximum transport maximum
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • stimulant
    ÀڱؼºÀÇ;ÈïºÐ½ÃŰ´Â
  • maximum
    ÃÖ´ë; ÃÖ°í; ±ØÇÑ
  • strength
    Èû,¼¼·Â,ÀåÁ¡
  • field strength
    ÀåÀÇ ¼¼±â;Àü°è °­µµ
  • impact strength
    (Àç·áÀÇ)Ãæ°Ý °­µµ
  • maximum
    ÃÖ´ëÇѵµ
  • maximum dose
    (¾àÀÇ) ±Ø·®
  • maximum permissible dosage
    (¹æ»ç´É) ÃÖ´ë Çã¿ë Á¶»ç Àû·®
  • maximum thermometer
    ÃÖ°í ¿Âµµ°è
  • radio field intensity (strength)
    ÀüÆÄ °­µµ;ÀüÀÚÀå °­µµ
  • strength
    Èû;°­Çϱâ;°­µµ;³óµµ;º´·Â;È¿·Â;ÀúÇ×(³»±¸)·Â;ÈûÀÌ µÇ´Â °Í;ÀÇÁö;on the ~ of;...À» ÀÇÁöÇÏ¿©(¹Ð°í)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á